Patents by Inventor Medivation Technologies, Inc.

Medivation Technologies, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDO[4,3-B]INDOLES AND METHODS OF USE
    Publication number: 20130184304
    Abstract: This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
    Type: Application
    Filed: March 8, 2013
    Publication date: July 18, 2013
    Applicant: Medivation Technologies, Inc.
    Inventor: Medivation Technologies, Inc.
  • TETRACYCLIC COMPOUNDS
    Publication number: 20130131054
    Abstract: This disclosure relates to new tetracyclic compounds that may be used to modulate a histamine receptor in an individual. The compounds in one embodiment are tetracyclic[4,3-b]indoles. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
    Type: Application
    Filed: December 21, 2012
    Publication date: May 23, 2013
    Applicant: Medivation Technologies, Inc.
    Inventor: Medivation Technologies, Inc.
  • PYRIDO[3,4-B]INDOLES AND METHODS OF USE
    Publication number: 20130131077
    Abstract: This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical-compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
    Type: Application
    Filed: December 21, 2012
    Publication date: May 23, 2013
    Applicant: Medivation Technologies, Inc.
    Inventor: Medivation Technologies, Inc.
  • PYRIDO[3,4-B]INDOLES AND METHODS OF USE
    Publication number: 20130123277
    Abstract: This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in the variety of therapeutic application, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or neuronal disorder.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 16, 2013
    Applicant: Medivation Technologies, Inc.
    Inventor: Medivation Technologies, Inc.
  • PYRIDO[3,4-B]INDOLES AND METHODS OF USE
    Publication number: 20130079352
    Abstract: This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
    Type: Application
    Filed: November 16, 2012
    Publication date: March 28, 2013
    Applicant: Medivation Technologies, Inc.
    Inventor: Medivation Technologies, Inc.